🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sara Tabatabai

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-5498-7176
Biochemistry, Genetics and Molecular BiologyEconomics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.104Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Quality of treatment selection for Medicare beneficiaries with cancer.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.140
Top 78%
0.104DataRank
Top 78%1 citations

Aaron Philip Mitchell, Akriti Mishra Meza, Hannah E. Fuchs, Sara Tabatabai, Nirjhar Chakraborty +11 more

Papers

Driven by 10 papers — median percentile 22. Top paper: “The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system”.

The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07433-4
N/A
0.359DataRank · unranked
7 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +18 more

Quality of treatment selection for Medicare beneficiaries with cancer.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.140
Top 78%
0.104DataRank
Top 78%1 citations

Aaron Philip Mitchell, Akriti Mishra Meza, Hannah E. Fuchs, Sara Tabatabai, Nirjhar Chakraborty +11 more

Provider- and facility-level factors in relation to patients’ receipt of chemotherapy, time to chemotherapy initiation, and receipt of guideline regimens: Results from the optimal breast cancer chemotherapy dosing study.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.540
N/A
0DataRank · unranked
0 citations

Kelli O’Connell, Jenna Bhimani, Isaac J. Ergas, Narre Heon, Grace B Gallagher +15 more

Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019

Breast Cancer Research(2024)10.1186/s13058-024-01822-9
N/A
0DataRank · unranked
11 citations

Kelli O’Connell, Isaac J. Ergas, Marilyn J. Foley, Grace Gallagher, Jennifer J. Griggs +17 more

Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I–IIIA breast cancer

International Journal of Cancer(2024)10.1002/ijc.35053
N/A
0DataRank · unranked
4 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +19 more

Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0360
N/A
0DataRank · unranked
2 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael P. Burganowski-Doud, Isaac J. Ergas +18 more

Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00833-9
N/A
0DataRank · unranked
1 citations

Kelli O’Connell, Grace B Gallagher, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +19 more

Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf314
N/A
0DataRank · unranked
1 citations

Kelli O’Connell, Jenna Bhimani, Grace Gallagher, Victoria Blinder, Rachael Doud +19 more

Evaluation of methods to identify chemotherapy‐related hematologic toxicities in real‐world settings

International Journal of Cancer(2025)10.1002/ijc.70266
N/A
0DataRank · unranked
0 citations

Kelli O’Connell, Jenna Bhimani, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +20 more

The evolving landscape of chemotherapy for the treatment of early-stage breast cancer from 2006-2019: Results of a retrospective cohort study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6600
N/A
0DataRank · unranked
0 citations

Kelli O’Connell, Rachael Burganowski, Isaac J. Ergas, Grace B Gallagher, Jennifer J. Griggs +15 more